lithium carbonate has been researched along with scopolamine hydrobromide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Abreu, MS; Barcellos, LJG; Giacomini, ACVV; Piato, A; Zanandrea, R | 1 |
2 other study(ies) available for lithium carbonate and scopolamine hydrobromide
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Lithium prevents scopolamine-induced memory impairment in zebrafish.
Topics: Animals; Antidepressive Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Lithium Carbonate; Male; Maze Learning; Memory Disorders; Motor Activity; Muscarinic Antagonists; Scopolamine; Zebrafish | 2018 |